Health related quality of life in Iranian patients with irritable bowel syndrome: Reliability and validity of the Persian version of the IBS-QOL

Iranian Red Crescent Medical Journal

Volumn 15, Issue 8, 2013, Pages 723-728

  Jafari, Peyman ^a   Asadollahi, Zahra ^a   Moini, Maryam ^b   Mirzaie, Mahdi Seyed ^c,d  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Irritable bowel syndrome; Quality of life; Questionnaires

Indexed keywords

ABDOMINAL PAIN; ADULT; ARTICLE; CORRELATION ANALYSIS; CRONBACH ALPHA COEFFICIENT; CROSS-SECTIONAL STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PERSIAN VERSION OF THE IBS QOL QUESTIONNAIRE; QUALITY OF LIFE; VALIDITY;

EID: 84885731667     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: 10.5812/ircmj.4605     Document Type: Article

References (27)

1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130(5):1480-91.
2. Boyce PM, Koloski NA, Talley NJ. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterol. 2000;95(11):3176-83.
3. Amouretti Michel, Le Pen Claude, Gaudin Anne-Francoise, Bommelaer Gilles, Frexinos Jacques, Ruszniewski Philippe, et al. Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL). Gastroentérologie Clinique et Biologique. 2006;30(2):241-246.
4. Heaton KW, O'Donnell LJ, Braddon FE, Mountford RA, Hughes AO, Cripps PJ. Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. Gastroenterology. 1992;102(6):1962-7.
5. Cremonini F, Talley NJ. Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors. Gastroenterol Clin North Am. 2005;34(2):189-204.
6. Talley Nicholas J, Gabriel Sherine E, Harmsen W Scott, Zinsmeister Alan R, Evans Roger W. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology. 1995;109(6):1736-1741.
7. Everhart JE, Renault PF. Irritable bowel syndrome in office-based practice in the United States. Gastroenterology. 1991;100(4):998-1005.
8. Pan Guozong, Lu Sucai, Ke Meigun, Han S, Guo H, Fang X. Epidemiologic study of the irritable bowel syndrome in Beijing: stratified randomized study by cluster sampling. Chinese Med J. 2000;113(1):35-39.
9. Drossman DA, Patrick DL, Whitehead WE, Toner BB, Diamant NE, Hu Y, et al. Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol. 2000;95(4):999-1007.
10. Hoseini-Asl MK, Amra B. Prevalence of irritable bowel syndrome in Shahrekord, Iran. Indian J Gastroenterol. 2003;22(6):215-6.
11. Mahmudi Sousan, Pourshams Akram, Akbari MohammadReza, Malekzadeh Reza. The prevalence of irritable bowel syndrome and gastroesophageal reflux disease among Tehran University students. Govaresh. 2012;8(4):159-162.
12. Masoumi SJ, Moradi Fariba, Mehrabani D, Khademolhosseni F, Mostaghni A, Zare N, et al. Prevalence and Quality of Life in Qashqai Migrating No-mads with Irritable Bowel Syndrome in Southern Iran. Iranian Red Crescent Medical Journal. 2009;11(4):403-407.
13. Groll D, Vanner SJ, Depew WT, DaCosta LR, Simon JB, Groll A, et al. The IBS-36: a new quality of life measure for irritable bowel syndrome. Am J Gastroenterol. 2002;97(4):962-71.
14. Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci. 1998;43(2):400-11.
15. Akehurst RL, Brazier JE, Mathers N, O'Keefe C, Kaltenthaler E, Morgan A, et al. Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting. Pharmacoeconomics. 2002;20(7):455-62.
16. Blanchard EB, Lackner JM, Gusmano R, Gudleski GD, Sanders K, Keefer L, et al. Prediction of treatment outcome among patients with irritable bowel syndrome treated with group cognitive therapy. Behav Res Ther. 2006;44(3):317-37.
17. Drossman Douglas A, Toner Brenda B, Whitehead William E, Diamant Nicholas E, Dalton Chris B, Duncan Susan, et al. Cognitive behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders 1 1 This study was registered with ClinicalTrials. gov (trial registry no. NCT00006157). Gastroenterology. 2003;125(1):19-31.
18. Drossman DA, Whitehead WE, Toner BB, Diamant N, Hu YJ, Bangdiwala SI, et al. What determines severity among patients with painful functional bowel disorders? Am J Gastroenterol. 2000;95(4):974-80.
19. Kanazawa M, Drossman DA, Shinozaki M, Sagami Y, Endo Y, Palsson OS, et al. Translation and validation of a Japanese version of the irritable bowel syndrome-quality of life measure (IBS-QOL-J). Biopsychosoc Med. 2007;1:6.
20. Park JM, Choi MG, Oh JH, Cho YK, Lee IS, Kim SW, et al. Cross-cultural validation of Irritable Bowel Syndrome Quality of Life in Korea. Dig Dis Sci. 2006;51(8):1478-84.
21. Wang W, Pan G, Qian J. [Cognitive therapy for patients with refractory irritable bowel syndrome]. Zhonghua Nei Ke Za Zhi. 2002;41(3):156-9.
22. Whitehead WE, Levy RL, Von Korff M, Feld AD, Palsson OS, Turner M, et al. The usual medical care for irritable bowel syndrome. Aliment Pharmacol Ther. 2004;20(11-12):1305-15.
23. Drossman DA, Talley NJ, Whitehead WE, Thompson WG, Coraz-Drossman DA, Talley NJ, Whitehead WE, Thompson WG, Corazziari E. Research diagnostic questions for functional gastrointestinal disorders: Rome II Modular Questionnaire:Investigations and Respondent Forms. In: Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, McLean VA, editors. Rome II The Functional Gastrointestinal Disorders 2nd ed: Degnon Associates; 2000. p. 669-714.
24. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11(2):395-402.
25. Nunnally JC. Psychometric Theory 3E. McGraw-Hill Education (India) Pvt Limited; 2010.
26. Fayers PM, Machin D. Quality of life: the assessment, analysis and interpretation of patient-reported outcomes. Wiley; 2007.
27. Huang WW, Zhou FS, Bushnell DM, Diakite C, Yang XH. Cultural adaptation and application of the IBS-QOL in China: a disease-specific quality-of-life questionnaire. Qual Life Res. 2007;16(6):991-6.